
Amelparib hydrochloric hydrate
CAS No. 1449233-60-6
Amelparib hydrochloric hydrate( JPI-289 | JPI289 )
Catalog No. M11930 CAS No. 1449233-60-6
Amelparib hydrochloric hydrate (JPI-289, JPI289) is a novel potent, water soluble PARP-1 inhibitor with IC50 of 18.5 nM, inhibits cellular PAR formation with IC50 of 10.7 nM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameAmelparib hydrochloric hydrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionAmelparib hydrochloric hydrate (JPI-289, JPI289) is a novel potent, water soluble PARP-1 inhibitor with IC50 of 18.5 nM, inhibits cellular PAR formation with IC50 of 10.7 nM.
-
DescriptionAmelparib hydrochloric hydrate (JPI-289, JPI289) is a novel potent, water soluble PARP-1 inhibitor with IC50 of 18.5 nM, inhibits cellular PAR formation with IC50 of 10.7 nM; does not affect cell viability up to 1 mM in rat cortical neuronal cells; attenuates PARP activity restores ATP and NAD+ levels in oxygen glucose deprived (OGD) rat cortical neurons, reduces apoptosis-associated molecules such as apoptosis inducing factor (AIF), cytochrome C and cleaved caspase-3 in the OGD model; JPI-289 is a potential neuroprotective agent which could be useful as a treatment for acute ischaemic stroke.Stroke Phase 2 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsJPI-289 | JPI289
-
PathwayCell Cycle/DNA Damage
-
TargetPARP
-
RecptorPARP
-
Research AreaNeurological Disease
-
IndicationStroke
Chemical Information
-
CAS Number1449233-60-6
-
Formula Weight452.373
-
Molecular FormulaC19H31Cl2N3O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCOC1=CC(=CC2=C1C3=C(CCCN3)C(=O)N2)CN4CCOCC4.O.O.Cl.Cl
-
Chemical Name10-ethoxy-8-(morpholinomethyl)-2,3,4,6-tetrahydrobenzo[h][1,6]naphthyridin-5(1H)-one dihydrochloride dihydrate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kim Y, et al. Clin Exp Pharmacol Physiol. 2017 Jun;44(6):671-679.
2. Kim Y, et al. Mol Neurobiol. 2018 Jan 30. doi: 10.1007/s12035-018-0910-6.
molnova catalog



related products
-
4-amino-1,8-Naphthal...
4-amino-1,8-Naphthalimide (4-ANI) is a PARP inhibitor with IC50 of 180 nM.
-
SRI-011381
SRI-011381, a new-type agonist of the TGF-beta signaling pathway, is utilized in the treatment of Alzheimer's disease.
-
5-amino-1,2-dihydroi...
5-aminoisoquinolin-1(2H)-one is the inhibitor of calf thymus PARP1.